Compounds > ro 46-2005
Page last updated: 2024-09-03

ro 46-2005 and Muscle Contraction

ro 46-2005 has been researched along with Muscle Contraction in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (66.67)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hosaka, T; Kawanishi, H; Kawase, Y; Kikkawa, K; Kushiyama, E; Morimoto, H; Shimadzu, H; Yamada, K; Yamauchi-Kohno, R; Yasuda, K1
Kataoka, K; Kurihara, H; Kurihara, Y1
Breu, V; Clozel, M; Gray, GA; Löffler, BM1
Buchan, KW; Magnusson, H; Rabe, KF; Sumner, MJ; Watts, IS1
Battistini, B; Fournier, A; Vane, JR; Warner, TD1
Breu, V; Burri, K; Cassal, JM; Clozel, M; Fischli, W; Gray, GA; Hirth, G; Löffler, BM; Müller, M; Neidhart, W1

Reviews

1 review(s) available for ro 46-2005 and Muscle Contraction

ArticleYear
[Endothelin and essential hypertension].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 9

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Drug Design; Endothelin Receptor Antagonists; Endothelin-1; Humans; Hypertension; Mice; Mice, Knockout; Muscle Contraction; Muscle, Smooth, Vascular; Peptides, Cyclic; Pyrimidines; Receptors, Endothelin; Sulfonamides

2004

Other Studies

5 other study(ies) available for ro 46-2005 and Muscle Contraction

ArticleYear
Potent and selective ET-A antagonists. 1. Syntheses and structure-activity relationships of N-(6-(2-(aryloxy)ethoxy)-4-pyrimidinyl)sulfonamide derivatives.
    Journal of medicinal chemistry, 2001, Oct-11, Volume: 44, Issue:21

    Topics: Animals; Antihypertensive Agents; Aorta; Binding Sites; Blood Pressure; Cell Line; Cloning, Molecular; Endothelin Receptor Antagonists; Humans; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Pyrimidines; Rats; Receptor, Endothelin A; Receptors, Endothelin; Structure-Activity Relationship; Sulfonamides; Swine

2001
In vivo pharmacology of Ro 46-2005, the first synthetic nonpeptide endothelin receptor antagonist: implications for endothelin physiology.
    Journal of cardiovascular pharmacology, 1993, Volume: 22 Suppl 8

    Topics: Anesthesia; Animals; Arginine; Blood Pressure; Endothelin Receptor Antagonists; Endothelins; Heart Rate; In Vitro Techniques; Injections, Intravenous; Male; Muscle Contraction; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pyrimidines; Rats; Rats, Wistar; Sulfonamides

1993
Characterisation of the endothelin receptor mediating contraction of human pulmonary artery using BQ123 and Ro 46-2005.
    European journal of pharmacology, 1994, Aug-01, Volume: 260, Issue:2-3

    Topics: Aged; Amino Acid Sequence; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Female; Humans; In Vitro Techniques; Male; Middle Aged; Molecular Sequence Data; Muscle Contraction; Muscle, Smooth, Vascular; Peptides, Cyclic; Pulmonary Artery; Pyrimidines; Receptors, Endothelin; Sulfonamides; Vasoconstrictor Agents; Viper Venoms

1994
Comparison of PD 145065 and Ro 46-2005 as antagonists of contractions of guinea-pig airways induced by endothelin-1 or IRL 1620.
    European journal of pharmacology, 1994, Feb-11, Volume: 252, Issue:3

    Topics: Animals; Bronchoconstriction; Endothelin Receptor Antagonists; Endothelins; Guinea Pigs; Lung; Male; Muscle Contraction; Muscle, Smooth; Oligopeptides; Peptide Fragments; Pyrimidines; Sulfonamides

1994
Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist.
    Nature, 1993, Oct-21, Volume: 365, Issue:6448

    Topics: Administration, Oral; Animals; Endothelin Receptor Antagonists; Endothelins; Humans; In Vitro Techniques; Male; Molecular Structure; Muscle Contraction; Pyrimidines; Rats; Rats, Wistar; Sulfonamides; Vasoconstriction

1993